Health
Olfactory and gustatory impairments in COVID‐19 patients: Role in early diagnosis and interferences by concomitant drugs – Ferraro – – British Journal of Clinical Pharmacology – Wiley Online Library – Wiley
Click on the article title to read more.
The COVID19 pandemic spread worldwide with over 38 million confirmed cases and more than 1 million deaths as of October 15, 2020. The clinical manifestations of SARSCoV2 infection range from asymptomatic to lifethreatening pneumonia, with the main symptoms being respiratory and gastrointestinal in nature. However, several patients report neurological symptoms including smell and taste impairments, such as anosmia, cacosmia, ageusia and dysgeusia.1 Although the spread of the disease has been favoured…
-
Noosa News14 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News15 hours agoMotorcyclist dies in crash with truck
-
Noosa News16 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General21 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging